Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnosis of Melanoma with 61Cu-Labeled PET Tracer.
Bunda S, Kálmán-Szabó I, Lihi N, Képes Z, Szikra D, Peline Szabo J, Timári I, Szücs D, May NV, Papp G, Trencsényi G, Kálmán FK. Bunda S, et al. Among authors: kalman szabo i. J Med Chem. 2024 Jun 13;67(11):9342-9354. doi: 10.1021/acs.jmedchem.4c00479. Epub 2024 May 16. J Med Chem. 2024. PMID: 38753457
β-Tricalcium Phosphate-Modified Aerogel Containing PVA/Chitosan Hybrid Nanospun Scaffolds for Bone Regeneration.
Boda R, Lázár I, Keczánné-Üveges A, Bakó J, Tóth F, Trencsényi G, Kálmán-Szabó I, Béresová M, Sajtos Z, D Tóth E, Deák Á, Tóth A, Horváth D, Gaál B, Daróczi L, Dezső B, Ducza L, Hegedűs C. Boda R, et al. Among authors: kalman szabo i. Int J Mol Sci. 2023 Apr 20;24(8):7562. doi: 10.3390/ijms24087562. Int J Mol Sci. 2023. PMID: 37108742 Free PMC article.
In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
Kálmán-Szabó I, Képes Z, Fekete A, Vágner A, Nagy G, Szücs D, Gyuricza B, Arató V, Varga J, Kárpáti L, Garai I, Mándity I, Bruchertseifer F, Elek J, Szikra D, Trencsényi G. Kálmán-Szabó I, et al. J Pharm Biomed Anal. 2023 May 30;229:115374. doi: 10.1016/j.jpba.2023.115374. Epub 2023 Mar 28. J Pharm Biomed Anal. 2023. PMID: 37001274 Free article.
In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Csikos C, Vágner A, Nagy G, Kálmán-Szabó I, Szabó JP, Ngo MT, Szoboszlai Z, Szikra D, Krasznai ZT, Trencsényi G, Garai I. Csikos C, et al. Among authors: kalman szabo i. Diagnostics (Basel). 2023 Jan 8;13(2):236. doi: 10.3390/diagnostics13020236. Diagnostics (Basel). 2023. PMID: 36673046 Free PMC article.
In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography.
Szabó JP, Csige K, Kálmán-Szabó I, Arató V, Opposits G, Jószai I, Kertész I, Képes Z, Méhes G, Fenyvesi F, Hajdu I, Trencsényi G. Szabó JP, et al. Among authors: kalman szabo i. Int J Pharm. 2023 Jan 5;630:122462. doi: 10.1016/j.ijpharm.2022.122462. Epub 2022 Nov 30. Int J Pharm. 2023. PMID: 36462739 Free article.
In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models.
Képes Z, Barkóczi A, Szabó JP, Kálmán-Szabó I, Arató V, Garai I, Árkosy P, Jószai I, Deák Á, Kertész I, Hajdu I, Trencsényi G. Képes Z, et al. Among authors: kalman szabo i. Int J Mol Sci. 2022 Oct 27;23(21):13060. doi: 10.3390/ijms232113060. Int J Mol Sci. 2022. PMID: 36361850 Free PMC article.
12 results